| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Core Earnings | $1.1B Q4 ($4.60 per share) | $866M Q1 ($3.09 per share) | Sequential decline but 20.3% trailing 12-month ROE |
| Business Insurance Written Premium Growth | 7% Q4 | 6% Q1 | 100 bps deceleration but outpacing market |
| Small Business Written Premium Growth | 9% Q4 | 8% Q1 | 100 bps slowdown but still strong |
| BI Underlying Combined Ratio | 88.1% Q4 | 89.2% Q1 | 110 bps deterioration, seasonal normalization |
| BI Renewal Pricing Ex-Comp | 6.1% Q4 | 6.0% Q1 | 10 bps deceleration, remarkable stability |
| Personal Insurance Underlying Combined Ratio | 84.3% Q4 | 85.0% Q1 | 70 bps deterioration but still profitable |
| Personal Insurance Written Premium | -2% Q4 | -6% Q1 | 400 bps acceleration in decline |
| Employee Benefits Core Earnings Margin | 7.6% Q4 | 6.9% Q1 | 70 bps compression despite strong sales |
| Group Disability Loss Ratio | 70.5% Q4 | 72.7% Q1 | 220 bps deterioration, trend reversal |
| Net Investment Income | $832M Q4 | $739M Q1 | $93M sequential decline, LP normalization |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.